Neuca SA
WSE:NEU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Neuca SA
Revenue
Neuca SA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Neuca SA
WSE:NEU
|
Revenue
zł13.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Neuca SA
Glance View
NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
See Also
What is Neuca SA's Revenue?
Revenue
13.6B
PLN
Based on the financial report for Dec 31, 2025, Neuca SA's Revenue amounts to 13.6B PLN.
What is Neuca SA's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Neuca SA have been 7% over the past three years , 8% over the past five years , and 7% over the past ten years .
